We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Fighting to end tuberculosis

Dr Helen McShane at the University of Oxford and the Oxford-Emergent Tuberculosis Consortium Ltd have received a Strategic Award to part-fund the first trial to test efficacy of the new TB vaccine candidate, MVA85A, for potential efficacy in South African infants.

In the video below, Dr McShane discusses the new vaccine candidate and these trials (running time: 4 min 53 s).

Sorry, but you need Flash Player 8 or higher to view the media player Download Flash

Read the transcript [PDF 148KB]

Share |
Home  >  Funding  >  Technology transfer  >  Technology transfer showcase  > Fighting to end tuberculosis
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888